05/18/2026
Regenerative technologies continue to grow throughout the animal health industry, offering veterinarians a variety of biologic and tissue-based tools to support different clinical applications. While each technology category has unique characteristics, most are designed to assist with structural support, tissue management, and the body’s natural repair environment.
🔬 Common categories of regenerative technologies in veterinary medicine include:
▪️ Autologous Technologies
Derived directly from the patient receiving treatment. Examples may include platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), IRAP, and stem cell preparations collected from the same animal.
▪️ Allografts
Biologic tissues or cells sourced from a donor of the same species. Examples may include equine-to-equine or canine-to-canine tissue grafts, stem cell products, or amniotic-derived technologies.
▪️ Xenografts / Xenogeneic Technologies
Biologic materials sourced from a different species than the recipient animal. These technologies are commonly used for structural extracellular matrix (ECM) support, wound coverings, scaffold materials, and certain surgical applications.
As regenerative medicine continues to evolve, veterinarians are increasingly combining biologic technologies with rehabilitation, diagnostics, surgery, and multimodal case management to support individualized patient care.
At AniCell BioTech, our focus remains on providing veterinarians with amniotic-derived technologies for equine and companion animal applications while supporting continued education and responsible clinical implementation. 💥
